Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for cardiovascular disease.

K F Kozarsky1

  • 1GlaxoSmithKline, King of Prussia, PA 19406, USA. Karen_F_Kozarsky@sbphrd.com

Current Opinion in Pharmacology
|November 21, 2001
PubMed
Summary

Cardiovascular gene therapy clinical trials are advancing for conditions like ischemia and restenosis. Sophisticated gene delivery vectors enhance safety through targeted delivery and regulated gene expression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene therapy of hypercholesterolemic disorders.

Trends in cardiovascular medicine·2011
Same author

Selective cholesteryl ester uptake from high density lipoprotein by human first trimester and term villous trophoblast cells.

Placenta·2003
Same author

Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor.

The Journal of biological chemistry·2000
Same author

Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse.

Arteriosclerosis, thrombosis, and vascular biology·2000
Same author

The HDL receptor SR-BI: a new therapeutic target for atherosclerosis?

Molecular medicine today·1999
Same author

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor.

The Journal of clinical investigation·1997

Area of Science:

  • Cardiovascular Medicine
  • Gene Therapy
  • Molecular Biology

Background:

  • Gene therapy offers a promising avenue for treating cardiovascular diseases.
  • Clinical trials are actively investigating its efficacy for conditions such as peripheral and myocardial ischemia, and restenosis.

Purpose of the Study:

  • To highlight the current progress and advancements in cardiovascular gene therapy.
  • To discuss the improved safety profiles of emerging gene delivery technologies.

Main Methods:

  • Utilizing advanced gene delivery vectors.
  • Employing tissue-specific targeting strategies.
  • Implementing disease-inducible promoters for regulated gene expression.

Main Results:

  • Clinical trials are underway for cardiovascular gene therapy applications.
  • Sophisticated delivery vectors demonstrate enhanced targeting capabilities.
  • Regulated gene expression through disease-inducible promoters contributes to improved safety.

Conclusions:

  • Cardiovascular gene therapy is progressing towards clinical application.
  • Advanced delivery systems are crucial for enhancing the safety and efficacy of gene therapy.
  • Targeted delivery and regulated gene expression are key innovations improving patient outcomes.

Related Experiment Videos